BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.310
+0.060 (4.80%)
At close: Jun 26, 2026, 4:00 PM EDT
1.300
-0.010 (-0.76%)
After-hours: Jun 26, 2026, 7:53 PM EDT
BioXcel Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for BioXcel Therapeutics stock have an average target of 7.67, with a low estimate of 1.00 and a high estimate of 17. The average target predicts an increase of 485.50% from the current stock price of 1.31.
Analyst Consensus: Buy
* Price targets were last updated on Apr 10, 2026.
Analyst Ratings
The average analyst rating for BioXcel Therapeutics stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $5 | Buy | Reiterates | $5 | +281.68% | Apr 10, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Reiterates $1 | Sell | Reiterates | $1 | -23.66% | Mar 27, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $17 | Buy | Initiates | $17 | +1,197.71% | Mar 17, 2026 |
Financial Forecast
Revenue This Year
769.92K
from 642.00K
Increased by 19.93%
Revenue Next Year
18.93M
from 769.92K
Increased by 2,359.15%
EPS This Year
-2.62
from -5.71
EPS Next Year
-1.54
from -2.62
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 769,920 | 30.7M | |
| Avg | 769,920 | 18.9M | |
| Low | 769,920 | 5.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 19.9% | 3,887.4% | |
| Avg | 19.9% | 2,359.1% | |
| Low | 19.9% | 591.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -2.62 | -1.54 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.